MannKind Corp. (MNKD)

[JLS]

No, I'm not comparing cars.

I'm comparing one inhaleable diabetes drug to another inhaleable diabetes drug.

That is not a paradigm shift.

A paradigm shift might be going from an injectable drug to an inhaleable drug for the first time ever. MannKind gets no credit for that. I say "might" because asthma sufferers have been using inhalers for a long time, so the concept of inhaled delivery is not new.

In fact: German researchers first introduced the idea of inhalable insulin in 1924. [Justin Gillis (January 28, 2006). "Inhaled Form of Insulin Is Approved". The Washington Post. Retrieved 2007-10-21.]

Paradigm shift: a fundamental change in approach or underlying assumptions. A major change in how some process is accomplished. A paradigm shift can happen when new technology is introduced that radically alters the production process of a good.

"Exubera ... launched in an era where the internet was young"

Exubera was pulled in October 2007. There was nothing young about the internet then.

Probably the most important single number to follow is the 4-week average of weekly refills. For the last month, that average is 113. My university physics lecture room would seat more people than that.

As for current weekly new sales of Afrezza, how many of those are free samples?

I'll let the market decide on Monday.